David Einhorn's position in Gain Therapeutics is currently worth $1.88 Million. That's 0.09% of their equity portfolio (33rd largest holding). The investor owns 3.67% of the outstanding Gain Therapeutics stock. The investor's estimated purchase price is $7.33 Million, resulting in a loss of 74%.